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Background:  Norovirus  P2  domain  is commonly  used  to  extrapolate  transmission  within  an  outbreak
(OB)  setting.  The  current  deﬁnition  is  that  transmission  among  cases  is  considered  to be proven  when  no
sequence variation  is  found.
Objectives:  Previous  studies  have  shown  a  high  mutation  rate  and  errors  during  replication  of the
norovirus  genome,  therefore  the  validity  of  this  criterion  must  be  evaluated.
Study design:  Sequences  of the  P2  domain  were  obtained  from  patients  and  health  care  workers  sampled
during  4  prospectively  GII.4 outbreaks.  Fecal  samples  were  tested  by  RT-PCR  for  presence  of  norovirus
RNA  against  a  standard  control  preparation  to allow  quantiﬁcation.  Estimated  time  of  onset  of  shedding
was derived  from  shedding  kinetics  modeled  on  data  from  sequential  sampling.  Thereby  P2 sequence
variation  could  be linked  to estimated  total  virus  excretion  in individual  subjects.
Results:  In all  the  outbreaks,  P2  domain  variation  was  found  that  resulted  in  unique  codon  changes  in
some  patients.  Mutations  were  found  in 14%  of  initial  samples  and  >50%  of  follow-up  samples  taken  from
patients  involved  in an  outbreak.  In three  patients,  aa mutations  was  observed  in or near sites  involved
in  host  or  antigen  binding.
Conclusions:  We  concluded  that  P2  domain  variation  increases  with  duration  of virus  shedding,  but  was
unrelated  to  total  amounts  of virus  shed.  Therefore,  we  propose  that  cluster  identiﬁcation  based  on
identical  sequences  should  be  relaxed  to  accommodate  minor  sequence  variation.  When  using sequence
data  to  support  outbreak  investigations,  sequence  diversity  should  be  interpreted  in relation  to  timing
of sampling  since  onset  of  illness.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.. Background
Noroviruses (NoV) are a major cause of gastroenteritis world-
ide and are most commonly associated with outbreaks in health
are settings.1 Onward transmission of noroviruses is common
hen guidelines for outbreak control are not applied rigorously.2
or developing effective control measures, a proper understanding
Abbreviations: NoV, norovirus; HCW, health care workers; OB, outbreaks; EMC,
niversity hospital.
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Open access under the Elsevier OA license.of the transmission patterns during outbreaks is needed, includ-
ing the role of healthcare workers and asymptomatic shedders.
Molecular typing of NoV-positive stool samples can be used to
determine links between individual cases. A systematic analysis
of genome diversity in a large dataset collected through the Food-
borne viruses of Europe network concluded that the optimal target
for sequence-based linking of cases was the capsid gene.3 For prac-
tical reasons, currently the P2 domain of the NoV is used.4–7 This
genome region is considered to be the most variable part of the
genome since it codes for the protruding domain of the capsid pro-
tein, which contains the receptor binding domain and important
epitopes targeted by antibodies that inhibit binding.8,9 In GII.4 NoV,
the P2 domain evolves by accumulation of mutations under selec-
tive pressure from host immunity.10–12 Accumulation of mutations
in this domain was  also shown in immunocompromised patients
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ith prolonged shedding of viruses.13 Recently the use of next
eneration sequencing identiﬁed minority variants present during
ransmission events.14
. Objectives
P2 domain sequencing has been used for identifying the trans-
ission pathways and links during outbreaks4–7 and identical P2
omain sequences are considered evidence for a cluster. However,
ith the high mutation rate of norovirus,15 nucleotide changes
ay  occur within a short time interval, raising the question what
ould be an appropriate minimum number of nucleotide changes
or deﬁning a cluster of cases connected by direct transmission
inks. This question is relevant because outbreaks may  be missed
ith common cluster detection algorithms that use time and space,
r pseudo-outbreaks may  occur when many patients are hospi-
alized during peak season.6,7 Therefore, we set out to quantify
2 domain variation, during four prospectively monitored out-
reaks in three nursing homes and a tertiary care hospital.16 We
ampled NoV-positive patients and health care workers (HCW),
dentiﬁed through an enhanced outbreak protocol irrespective of
heir symptom status. Variation in sequence data between and
ithin outbreaks, as well as variation between and within infected
ubjects was analyzed and correlated with the estimated number of
iruses shed by each individual. The results can be used to redeﬁne
riteria for linking of cases to outbreaks.
. Study design
We  prospectively monitored four GII.4 outbreaks starting from
anuary 2009 until March 2011 in the region of Rotterdam in the
niversity Hospital (EMC) and in nursing homes.16 Sampling was
ased on an enhanced outbreak investigation protocol focusing on
he identiﬁcation of possible sources and modes of transmission of
oV.16 The study protocol included random sampling irrespective
f symptoms of all patients and HCW on affected wards with NoV.
atients and their contacts involved in the outbreaks who  met  the
nclusion criteria of the study protocol were tested weekly until a
egative test was returned. Each case was conﬁrmed by sequenc-
ng region A (genotyping) followed by P2 domain sequencing.6,17
he amount of virus shed by each subject was estimated from real
ime RT-PCR analysis of all fecal samples, using RNA transcribed
rom a plasmid containing a sequence spanning all commonly used
iagnostic targets as a reference template,18 allowing us to inves-
igate correlation between virus excretion and P2 domain changes
ver time. Background sequences from the same geographic region
ere collected from patients outside the studied outbreaks, with
oV infection detected ≤2 days after admission.
.1. Sequence analysis
RNA fragments were reverse transcribed with random hexam-
rs (Invitrogen), yielding cDNA that was ampliﬁed by a nested PCR
nd subsequently sequenced using the ABI-PrismBigDye Termina-
or v3.0 Ready Reaction Cycle kit. The same primers were used for
mpliﬁcation and sequencing the P2 domain (primers 1st PCR: F:
′ gangatgtcttcacagtctctt 3′, R: 5′ cattcctgggggagtagaca 3′,4 Nested
rimers: F: 5′ gtgccacccacagttgag 3′, R: 5′ gggagtagacagtccaa 3′).
NA Sequences were entered and assembled in bionumerics 6.6.2
Applied Maths, Sint-Martens-Latem, Belgium) and evaluated man-
ally for their quality by looking for the number of ambiguities,
rrors, mismatches and deletions.
Sequences were aligned; genotype and variant assignment
as based on the RdRp region16 using the norovirus typing tool
http://www.rivm.nl/mpf/norovirus/typingtool).19 Full-length P2al Virology 56 (2013) 286– 292 287
domain sequences (600 nucleotide) were then subjected to pair-
wise analysis (UPGMA) to identify strains linked to the same
outbreak, and by advanced cluster analysis (maximum parsimony),
to compare diversity within and between outbreaks and robust-
ness of clustering. Sequence diversity within patient and between
patients within an outbreak was  assessed by comparing the min-
imum and maximum number of mismatches for each outbreak
separately. Translated sequences were reviewed to look for possible
directional amino acid mutations.
3.2. Sampling and virus shedding
To study the effect of sampling delay, the time of onset of
shedding was  estimated by extrapolation from modeled shedding
kinetics, based on data from all subjects with follow up samples
(Teunis et al., submitted for publication). An RNA standard template
was  used to translate CT values in fecal samples into an estimated
viral load. PCR based estimates of NoV shedding were then used
to calculate total numbers of viruses shed by sampled subjects,
allowing analysis of sequence variation against viral load, clinical
symptoms (symptomatic or asymptomatic), and occupational sta-
tus (HCW/patients). To characterize the rate of sequence variation
all data were pooled and the survivor function for sequence change
was  calculated, using a Kaplan–Meier estimator20 describing the
probability of any nucleotide changes versus time from onset of
shedding.
4. Results
4.1. Strain typing and clustering
The four GII.4 outbreaks occurred in 3 nursing homes and 1
university hospital. The ages of the included HCW/patients from
the hospital setting ranged from 25 to 77 and 54 to 77 years,
respectively. In the nursing homes, ages for the residents were high
(72–95 years), while for the HCW this ranged from 20 to 63 years.
Details of the outbreaks have been described elsewhere (15). In
total 175 HCW and 77 patients consented to enhanced case ﬁnding,
of which 50 HCW and 47 patients tested positive for NoV infection
(Table 1). Capsid gene sequencing was successful in 109 NoV posi-
tive stool samples from a total of 252 sampled cases, comprising 44
HCW and 37 patients.16 OB 4 yielded 48 sampled cases but the data
is not published yet. Failed sequences were repeatedly tested but
persistently failed to produce sequence information. The success of
sequencing was  unrelated to the levels of virus shedding (data not
shown).
Phylogenetic analysis of all P2 domain sequences showed a clear
discrimination of the four GII.4 outbreak clusters, but with mixed
results for OB 1: here, the outbreak strains segregated into three
different clusters: GII.4 2008 (17 cases) and 2 clusters belonging
to the GII.4 2006b variant lineage (2 cases each) (Fig. 1). As this
suggests that a minority of the patients was from a different, unre-
lated cluster, detailed molecular analysis was not performed for
these strains. Data retrieved from the hospital database showed
that one of the samples belongs to a nurse who was involved in
patient interviews. The other three subjects were patients who had
been admitted into the hospital. From the epidemiological data,
it was clear that one patient developed diarrhea after admission,
indicating a nosocomial infection.
Comparison of these results against the strain diversity observed
in the background dataset (deﬁned as sequences from patients
admitted with norovirus infection) showed that these were unique
and distinct from the outbreak sequences with few exceptions (4%)
(Fig. 1). In OB 4 a unique single case was observed who  showed
288 F.H.A. Sukhrie et al. / Journal of Clinical Virology 56 (2013) 286– 292
Table  1
Summary of cases and sequence data.
Location NoV cases (HCW/P) Nr cases with P2
domain sequence
(HCW/P)
Nr samples with
follow-up P2 domain
sequences, HCW/P
Maximum nr
nucleotide changes
within (patient/OB)a
OB 1 (GII.4 2008) Tertiary care Hosp. 15/7 13/2 3/2 0/22
OB  2 (GII.4 2010) Nursing home 14/10 15/8 3/13 2/2
OB  3 (GII.4 2010) Nursing home 12/16 11/15 0/4 1/2
OB  4 (GII.4 2010) Nursing home 9/14 5/12 0/3 1/15
44/3
a
s
4
s
r
a
b
w
s
d
F
(Total  50/47 
a Including all persons initially considered being part of the outbreak.
t least 15 nucleotide differences compared to the outbreak strain,
uggestive for an unrelated introduction.
.2. Within and between patient sequence diversity
The percentage nucleotide diversity based on P2 domain analy-
is (600 base pairs) between outbreaks (OBs) including all samples
anged from 6.3 to 7.3% of sequences different at genotype level,
nd from 0.7 to 1.2% at variant level. Sequence variation within out-
reaks was small (0–0.3%) and overlapped with sequence diversity
ithin subjects (0–0.3%). At the time of ﬁrst sampling 70 (86%) per-
ons of OB 1–4 (both patients and HCW) had an identical sequence,
esignated the outbreak strain consensus, whereas 6 (38%) were
ig. 1. Cluster analysis (maximum parsimony) showing diversity between and within h
white circles). Size of circle reﬂects number of sequences.7 6/22
shedding a virus with a single nucleotide change in the ﬁrst sample
and one person had a sequence with 2 nucleotide changes shortly
after onset of shedding. During follow-up, more nucleotide changes
were seen; in total 56% of follow-up samples tested yielded one or
more mutations.
Fig. 2 shows the timing of sampling in relation to the estimated
period of shedding, as estimated from the kinetics of shedding as
described elsewhere (Teunis et al., submitted for publication). The
sampling delay ranged from 0 to 23 days for symptomatic cases
with a median of 8.5 days since the estimated time of infection, and
3–7 days with a median of 5.4 days for asymptomatic cases. When
summarizing the rate of sequence change in a Kaplan–Meier plot,
sequence changes appeared from 4 days post onset of shedding.
ealthcare outbreaks against background diversity in community cases with NoV
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Fig. 2. Time course of virus shedding (modeled) and sequence changes for individual subjects in 4 NoV GII4 outbreaks. Squares indicate patients, diamonds health care
workers; ﬁlled symbols indicate symptomatic cases, empty symbols asymptomatic subjects. Size of the symbols indicates sequence change: smallest 0 bp change, medium
size  1 bp change, large symbols 2 bp change. One subject in OB 4 (bottom) has a sequence with 15 bp different (extra large square) from the consensus sequence for that
o hich 
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3utbreak. × indicates when a sample was taken that was  either negative, or for w
uration of shedding, from estimated onset (t = 0) to the time when the CT increase
he rate of increase in probability of a sequence change indicates
hat for samples collected at 3 weeks post onset of shedding there
s a 10% probability of (1–2) nucleotide changes (Fig. 3).
When the shedding data were combined with the sequence
ata no signiﬁcant association could be seen between shedding and
irus excretion or sequence variation, although patients seemed to
xcrete slightly higher numbers of viruses than HCWs, for a longer
eriod (Fig. 4).
.3. Codon changesIn total, 11 nucleotide changes resulted in codon changes (6 in
CW, 5 in patients). Codon changes were observed in OB’s 2 and
 only. In these outbreaks, almost all nucleotide sequence changesa sequence could not be established. Horizontal lines (gray) indicate (estimated)
e 40.
(8 out of 10 and 3 out of 3, respectively) were codon changes. Six of
the amino acid changes were located at positions in the P2 domain
that have been identiﬁed as informative sites, because they were
one of the marker mutations for global variants of GII.4 (S255G,
S310R, T340A, Y352H, S393N, K248R).11,12,21,22 Amino acid changes
at positions A256T and N373S were seen sporadically in the past, as
illustrated in Fig. 5 (Genbank accession numbers). The remaining
amino acid changes were unique, located at the following sites;
D312N, D312E, R411K. One of the mutations was located in the
histo-bloodgroup antigen-binding site (position 393), one in a posi-
tion that was resulted in an additional RGD motif on the GII4 2002
strains, and one mutation was near epitope A. No pattern of amino
acid changes was  observed to verify transmission between subjects
(Fig. 5).
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Fig. 3. Sequence changes Y-as (S/100%) over time after onset of shedding X-as (days),
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ahown by nonparametric (Kaplan–Meier) estimate of the probability of sequence
hange calculated for the complete set of infected subjects from all four outbreaks
mean curve and 95% range).
.4. Previously reported outbreaks
Background information from the hospital and the nursing
omes with OB 1, OB 2, OB 3 and OB 4 indicated that no outbreaks
ad been reported on the same department shortly before these
utbreaks were identiﬁed.
. Discussion
Molecular analysis can help deﬁne transmission pathways dur-
ng outbreaks, particularly when combined with metadata.5,6,17
or NoV the proposed molecular marker is the P2 domain, since
his domain is considered hypervariable thus providing sufﬁcient
esolution for use of sequence data for linking of cases (17). Accord-
ng to our results, each outbreak has a unique consensus sequence
ased on P2 domain homology. Phylogenetic analysis of P2 domain
equence data can therefore unravel pseudo-outbreaks and speciﬁ-
ally can serve to exclude strains that do not belong to the outbreak
Fig. 1). It can also provide information regarding the extent of
he outbreak, for instance concurrent sampling from the popula-
ion extraneous of the outbreak can provide additional linked cases
ased on the P2 domain homology.
ig. 4. Box plots (arithmetic mean, quartile box and 95% whiskers) of the duration of shedd
nd  asymptomatic cases without and with sequence changes. Also shown (bottom row): al Virology 56 (2013) 286– 292
More detailed analysis of the domain revealed that in addition
to diversity of the P2 domain between outbreaks there was minor
variation within each outbreak, and among follow-up samples from
individual patients and HCW. Most of the samples were collected
between 4 and 7 days of post onset illness when the transmis-
sion was most intense; however, the majority of the NT changes
occurred in a later stage (Fig. 2).
In the outbreaks studied here, the variation within the P2
domain does not exceed 2 nucleotide changes and therefore a
maximum number of nucleotide changes of 0.33%/600 bp is a con-
servative threshold to suspect a new introduction. The time interval
to the ﬁrst sequence change can be relevant for future outbreak
investigations, with changes observed as early as 4 days following
infection.
The position of each nucleotide change was unique and was
only found in single cases with one exception. This suggests that
minor sequence changes during NoV outbreaks are a random phe-
nomenon in otherwise healthy individuals. However, an indication
of immune driven selection is the ﬁnding that the majority of
mutations in follow-up samples were codon changes, with two
remarkable mutations: mutations in position 393 have been associ-
ated with alterations in histo-bloodgroup antigen binding patterns
of GII.4 strains,23 and therefore such strains potentially could tar-
get a different segment of the population. One mutation was at a
position adjacent to epitope A (position 373) and therefore poten-
tially inﬂuencing antibody binding. Amino acid changes at position
340 have been found in almost all GII4 variant transitions, and
therefore may  be signiﬁcant as well.12,21,22 While speculative, this
suggests that new variants may  arise quite rapidly in patients dur-
ing the course of a single infection. Still, an antibody response
has to be mounted after an infection since we do not know the
exposure history of the individuals involved. Although all of them
were adults and therefore most likely had experienced multiple
norovirus infections prior to the present one, given the high inci-
dence of these infections in the population.24
Obviously, more information is needed to deﬁne transition
to a new (epidemic) variant. In our study, we  found no evidence
of onward transmission of the viruses with potentially informa-
tive mutations. Without changes, affecting transmissibility such
variants would most likely not emerge as major strains, given
the omnipresence of competing strains circulating in the general
ing for HCW and patients without and with sequence changes, and for symptomatic
same for the estimated total numbers of viruses shed.
F.H.A. Sukhrie et al. / Journal of Clinical Virology 56 (2013) 286– 292 291
Fig. 5. Amino acid (AA) changes (informative sites) in P2 domain sequences of GGII.4 outbreak strains collected between 2009 and 2010. The informative sites throughout
the  protein are listed from left to right. AA numbering is indicated at the top, and names are given on the left. From top to bottom, blue color indicates identical amino acids,
and  overlapping AA of the background (Genbank accession numbers) are illustrated in brown and distinct AA with yellow. The red colors indicate the locations of insertions
of  the GGII.4 strains during the OB’s. Sequences in the middle area (brown) are reference GII4 strains. Symbol (–) indicates failure of partial sequence.
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opulation. This may  be different when such infections occur
utside the norovirus winter season, and a question is whether
hronic norovirus infection in immune-compromised individuals
ould serve as a reservoir for new variants.13
Finally, the sequence variations observed in the present study
emonstrate the need to reconsider the guidelines4–7 for identify-
ng clusters: the currently used cut-off of 100% identical P2 domain
equence should be relaxed to allow minor variations, thereby
otentially increasing the attribution of cases in health care sett-
ngs. Conversely, since the variation in the P2 domain is limited
ithin the same cluster, it is often difﬁcult to trace transmission
vents using only sequence data, particularly for deﬁning transmis-
ion between individual infected subjects. We  have established that
he resolution is insufﬁcient to conclusively identify links between
ndividuals within outbreaks (who infected whom): for such pur-
oses, more enhanced sequencing or sequencing of a larger part
f the genome is required by considering the presence of minority
ariants/quasi species.
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